EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Non-Regulated LC–MS/MS Bioanalysis in Support of Early Drug Development: A Novartis Perspective

Yunlin Fu iD, Wenkui Li iD, Franck Picard

Bioanalysis · 2023

DOI: 10.4155/bio-2022-0204 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioanalysis, 2023. Verfasst von Yunlin Fu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacokinetic Sciences - Drug Disposition, Novartis Institutes for BioMedical Research, One Health Plaza, East Hanover, NJ 07936, USA. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Body Fluids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scientifically qualified LC-MS/MS methods are essential for the determination of small molecule drug candidates and/or their metabolite(s) in support of various non-regulated safety assessment and in vivo absorption, distribution, metabolism and excretion studies in preclinical development. This article outlines an effective method development workflow to fit for this purpose. The workflow features a 'universal' protein precipitation solvent for efficient sample extraction, a mobile phase additive for managing chromatographic resolution and addressing carryover and an internal standard cocktail to select the best analogue internal standard to track the analyte of interest in LC-MS/MS. In addition, good practices are recommended to prevent bioanalytical pitfalls due to instability, non-specific binding and dosing vehicle-induced matrix effect. Proper handling of non-liquid matrix is also discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryBody FluidsChromatography, Liquid

Stichwörter der Autor:innen

LC–MS/MSbioanalysisinstabilityinternal standard cocktailmobile phase additivenon-liquid matrixnon-regulatednon-specific bindingpitfallsprotein precipitation

Autor:innen und Institutionen

  • Pharmacokinetic Sciences - Drug Disposition, Novartis Institutes for BioMedical Research, One Health Plaza, East Hanover, NJ 07936, USA.
  • Pharmacokinetic Sciences - Drug Disposition, Novartis Institutes for BioMedical Research, Basel, CH-4056, Switzerland.

ORCID-Profile: Yunlin Fu, Wenkui Li

Zitieren

APA

Fu, Y., Li, W., & Picard, F. (2023). Non-Regulated LC–MS/MS Bioanalysis in Support of Early Drug Development: A Novartis Perspective. Bioanalysis. https://doi.org/10.4155/bio-2022-0204

Vancouver

Fu Y, Li W, Picard F. Non-Regulated LC–MS/MS Bioanalysis in Support of Early Drug Development: A Novartis Perspective. Bioanalysis. 2023. doi:10.4155/bio-2022-0204

BibTeX
@article{Fu2023,
  author = {Fu, Yunlin and Li, Wenkui and Picard, Franck},
  title = {Non-Regulated LC–MS/MS Bioanalysis in Support of Early Drug Development: A Novartis Perspective},
  journal = {Bioanalysis},
  year = {2023},
  doi = {10.4155/bio-2022-0204}
}
Kostenlos starten →